Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis B Virus Therapy
Reports from University of Ferrara highlight recent research in hepatitis B virus therapy
November 12th, 2008
Researchers detail in 'The management of viral hepatitis in CKD patients: an unresolved problem,' new data in hepatitis B virus. According to a study from Ferrara, Italy, "Chronic kidney disease (CKD) patients in dialysis (HD) show peculiar, atypical features of clinical presentation and diseases (cardiovascular, metabolic, hematologic). This is also true for viral hepatitis infections, for which CKD patients represent an important risk group." "In the past, hepatitis B virus (HBV) was the major cause of viral hepatitis in end-stage renal disease (ESRD). However, the introduction of a rigorous infection-control strategy, routine screening of patients and staff for...
Source: Vaccine Weekly (2008-11-12)
|
